Back to top

Genentech granted priority review for Gazyva sBLA by FDA

Genentech, a member of Roche (RHHBY), announced that the FDA has granted priority review to the company’s supplemental biologics license applicatio...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Roche Holding AG (RHHBY)

Rogers Corporation (ROG)

Roper Technologies, Inc. (ROP)